USA Healthcare News Updates

The global  spectacles market  is projected to reach  USD 141.54 billion , thereby exhibiting a CAGR of 5.7% during the forecast period.  Fortune Business Insights™  published this information in a recent report, titled, “Spectacles Market Size, Share & Industry Analysis, By Product Type (Spectacles Frames and Spectacle Lenses), By Modality (Prescription and Over-the-counter) By Distribution Channel (Retail Store, Online Store, Ophthalmic Clinics), and Regional.” The report further mentions that the market stood at  USD 91.56 billion  in 2018. However, it is expected to gain momentum from the rising prevalence of ocular disorders, such as myopia, hypermetropia, and astigmatism. Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/sample/spectacles-market-101953 Industry Developments : July 2019:  EssilorLuxottica announced that the company is planning to buy 76.72% stakes in GrandVision, a Dutch optical retailer for an estimated USD 8.8 billio

The global  continuous renal replacement therapy (CRRT) market  is set to be positively impacted by rising technological advancements by renowned acute therapy manufacturers to offer enhanced dialysis care worldwide. Also, the expansion of extracorporeal therapies taking place in the ICU would affect the market positively. This information is given by Fortune Business Insights™ in a recent report, titled, “Continuous Renal Replacement Therapy (CRRT) Market Size, Share & Industry Analysis, By Product (Systems, and Consumables), By Modality (Slow continuous ultra-filtration {SCUF}, Continuous Venovenous Hemofiltration {CVVH}, Continuous Venovenous Haemodialysis {CVVHD}, and Continuous Venovenous Hemodiafiltration {CVVHDF), and Regional Forecast, 2019-2026.” The report further mentions that the CRRT market size was USD 845.7 million in 2018, and is projected to reach USD 1,502.1 million by 2026, exhibiting a CAGR of 7.5% during the forecast period. Request a Sample Copy of the Re

 The global  airway management devices market  size was valued at USD 1.81 billion in 2021 and is projected to reach a valuation of USD 1.89 billion in 2022. The market is expected to reach USD 2.55 billion by 2029 with a CAGR of 4.4% during the forecast period. Owing to rising cases of chronic diseases such as chronic obstructive pulmonary disease (COPD), cancer, chronic lung diseases, and others have put emphasis on better treatment of such conditions. Rising number of joint ventures and start-ups is projected to aid market development.  Fortune Business Insights™  shares this information in its report titled “ Airway Management Devices Market, 2022-2029. ” Get Sample PDF Brochure:   https://www.fortunebusinessinsights.com/enquiry/sample/airway-management-devices-market-107396 Key Industry Development January 2022-  Intersurgical Ltd announced the acquisition of Pulmodyne, Inc. to provide Intersurgical and for increased sales of the Pulmodyne ranges through the exte

The global  critical care antiarrhythmic drugs market  size is projected to reach USD 1,319.7 million by 2027, exhibiting a CAGR of 5.6% during the forecast period. Increasing prevalence of cardiovascular diseases (CVDs) around the world will be a major growth determinant for this market, highlights Fortune Business Insights™ in its report, titled “Critical Care Antiarrhythmic Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Beta Blockers, Calcium Channel Blockers, Sodium Channel Blockers, Potassium Channel Blockers, and Others),  By Disease Type (Supraventricular Arrhythmias, Ventricular Arrhythmias, and Others), and Regional Forecast, 2020-2027”. According to the World Health Organization (WHO), CVDs are the premier cause of global deaths, killing nearly 17.9 million people worldwide in 2016. Atrial fibrillation (AF) is the most frequent and the most commonly observed CVD. For example, the American Heart Association estimates that AF affects around 2.2 mil

The global  preeclampsia diagnostics market  size was valued at USD 1.03 billion in 2021 and reached USD 1.07 billion in 2022. The market is expected to reach USD 1.24 billion by 2029, exhibiting a CAGR of 2.2% during the forecast period. The rising prevalence of preeclampsia and increasing technological advancements in diagnostics procedures are expected to foster industry growth. Fortune Business Insights™ presents this information in its report titled “Preeclampsia Diagnostics Market, 2022-2029.” Key Industry Development July 2021:  LifeCell Diagnostics announced a comprehensive preeclampsia screening in India. The advanced screening detects biomarker, sFLT-1 (soluble FMS-like tyrosine kinase-1), which enables the prediction of the disease and helps in accurate diagnosis even in the third trimester. Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/preeclampsia-diagnostics-market-101519

The global  Nasal Drug Delivery Market size  is prognosticated to reach  USD 73.84 billion by 2026  attributable to the increasing number of the patient population and the rising prevalence of pulmonary disorders worldwide. This information is provided in a recently published report by Fortune Business Insights™ titled, “Nasal Drug Delivery Market Size, Share and Global Trend By Type (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Regional Forecast, 2019-2026.” As per the report’s description, the market size was  USD 42.38 billion in 2018  and is likely to exhibit a  CAGR of 7.3%  between 2019 to 2026. Request a Sample Copy of the Research Report:  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nasal-drug-delivery-market-100415 What are the Key Objectives of th

 The US Dialysis Services Market size was USD 25.87 billion in 2020. The market is expected to grow from USD 26.20 billion in 2021 to USD 32.46 billion in 2028 at a CAGR of 3.11% in the 2021-2028 period. This information is provided by Fortune Business Insights™ in its report titled, “ US Dialysis Services Market , 2021-2028.” Key Development: February 2021 : DaVita gained first position by comprising a safe telehealth platform called as DaVita Care Connect™, into its home dialysis segment. It is one of the numerous connective technologies in its collection of services intended to advanceresults and the care experience for patients determining to treat at home. As per our report, the number of patients undergoing dialysis continues to riserapidly in the U.S. each year and this is expected to boom demand of the service. The unhealthy and irregular lifestyle habits has too contributed in kidney failure and therefore raised the need to get dialysis. For example, according to

  The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption of targeted therapy for treating non-small cell lung cancer. According to a report published by  Fortune Business Insights , titled  ‘ Non-Small Cell Lung Cancer Therapeutics Market : Global Market Analysis, Insights and Forecasts, 2019-2026,’  the market value will rise substantially from US$ 16,011.7 Mn in 2018 to US$ 43,713.1 Mn by 2026. Fortune Business Insights has further predicted the market to exhibit an impressive CAGR of 13.4% between 2019 and 2026 due to exceptional advancements in targeted therapy in recent years. Such high growth can be attributable to the increasing demand for chemotherapy and targeted therapy. Furthermore, advantages of targeted therapy over other alternatives are in plenty. Driven by this, the demand for targeted therapy for diagnosis will increase, which in turn spurs growth in the global non-small cell lung cancer therapeutics market. B

 The  US blood transfusion diagnostics market  size was valued at USD 1.91 billion in 2021. The market is projected to grow from USD 2.20 billion in 2022 to USD 3.58 billion by 2029, exhibiting a CAGR of 7.2% during the forecast period. This information is presented by Fortune Business Insights, in its report titled, “US Blood Transfusion Diagnostics Market, 2022-2029.” Key Industry Development: June 2022 : Alba Bioscience Limited (QUOTIENT LIMITED) made an announcement that they have been granted the US FDA sanction for ORTHO Sera and ALBAclone blood grouping reagents. Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-blood-transfusion-diagnostics-market-107024 Drivers and Restraints: Rising Demand for Blood and Blood Components to Accelerate the US Blood Transfusion Diagnostics Market Growth The rising incidence of blood-related diseases such as hemophilia, leukemia, and thrombocytopen

  The global  OTC drugs market size  is projected to grow from USD 157.0 billion in 2021 to USD 233.6 billion in 2028. The rising number of private label products is set to affect growth positively. In the U.S., shares of these products reached 31.0% in 2018 from 26.0% in 2009. Also, numerous companies are collaborating with e-commerce platforms to launch their products on their platforms. Amazon.com, Inc., for instance, introduced Perrigo’s over-the-counter healthcare products in February 2018. Fortune Business Insights™ mentioned this in a published report, titled, “OTC Drugs Market, 2021-2028.” The report further states that the market stood at USD 148.0 billion in 2020. It is set to showcase a CAGR of 5.8% in the forecast period during 2021-2028. Request Sample PDF:  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/over-the-counter-otc-drugs-market-105433 Dr Reddy's Laboratories Unveils Famotidine Tablets in U.S. to Treat GERD In October 2020, Dr Reddy&#

 The global  critical care antiarrhythmic drugs market  size is projected to reach USD 1,319.7 million by 2027, exhibiting a CAGR of 5.6% during the forecast period. Increasing prevalence of cardiovascular diseases (CVDs) around the world will be a major growth determinant for this market, highlights Fortune Business Insights™ in its report, titled “Critical Care Antiarrhythmic Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Beta Blockers, Calcium Channel Blockers, Sodium Channel Blockers, Potassium Channel Blockers, and Others),  By Disease Type (Supraventricular Arrhythmias, Ventricular Arrhythmias, and Others), and Regional Forecast, 2020-2027”. According to the World Health Organization (WHO), CVDs are the premier cause of global deaths, killing nearly 17.9 million people worldwide in 2016. Atrial fibrillation (AF) is the most frequent and the most commonly observed CVD. For example, the American Heart Association estimates that AF affects around 2.2 mi

The global “ bowie dick test pack market ” size is expected to reach USD 254.6 million by 2028, exhibiting a CAGR of 5.2% during the forecast period. The growing demand for sterilization monitoring products to curb the spread of hospital acquired infections (HAIs) during invasive surgeries will have an excellent impact on the market growth in the forthcoming years, states Fortune Business Insights, in a report, titled “Bowie Dick Test Pack Market, 2021-2028.” The market size stood at USD 169.8 million in 2020. Requisite for Disinfectants to Boost Market amid COVID-19 The spread of coronavirus has resulted in heavy demand for sterilization and disinfectant products among biotech, pharmaceutical, and medical device companies. The growing prominence of sterile and infection-free medical instruments during the invasive surgical procedure will spur demand for bowie dick test packs during COVID-19. Moreover, the need for sterilization monitoring in hospitals, dental clinics, and oth